EQT to acquire Europa Biosite, a distributor of life science products
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 03 2025
0mins
Should l Buy ?
Source: PRnewswire
EQT's Acquisition of Europa Biosite: EQT Healthcare Growth has agreed to acquire a majority stake in Europa Biosite, a distributor of life science reagents, from Adelis Equity. This acquisition aims to enhance Europa Biosite's growth through digital upgrades, expanded product access, and continued mergers and acquisitions.
Support for Scientific Research: Europa Biosite supports over 60,000 researchers across Europe and North America by providing access to over ten million scientific products. With EQT's backing, the company plans to strengthen its supplier network and invest in digital tools to better serve the growing demand for research reagents.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
